Advanced search
Publication Cover
Patient Preference and Adherence Volume 10, 2016 - Issue
Submit an article Journal homepage
103
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population

Tatiana Dilla1 Medical Department, Lilly, Madrid, SpainCorrespondence[email protected]
,
Luís Lizan2 Outcomes’10, Jaime I University, Castellón, Spain
,
Silvia Paz2 Outcomes’10, Jaime I University, Castellón, Spain
,
Pilar Garrido3 Medical Oncology Department, University Hospital Ramon y Cajal, Madrid, Spain
,
Cristina Avendaño4 Clinical Pharmacology Department, Puerta de Hierro-Majadahonda Hospital, Madrid, Spain
,
Juan J Cruz-Hernández5 Salamanca Institute for Biomedical Research, University Hospital of Salamanca, Salamanca, Spain
,
Javier Espinosa6 Medical Oncology Department, General Hospital Ciudad Real, Ciudad Real, Spain
&
José A Sacristán1 Medical Department, Lilly, Madrid, Spain
 show all
Pages 1-7 | Published online: 18 Dec 2015

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Priyanka Gaitonde, Viktor Chirikov, Sneha Kelkar & Bengt Liljas. (2022) Considerations for the Utility of Real-World Evidence Beyond Trial Data in Advanced NSCLC: The Case of Frontline Tyrosine Kinase Inhibitors. Cancer Management and Research 14, pages 3421-3435.
Read now
M. Sakil Syeed, Nabin Poudel, Surachat Ngorsuraches, Jose Diaz & Nathorn Chaiyakunapruk. (2022) Measurement and valuation of the attributes of innovation of healthcare technologies: a systematic review. Journal of Medical Economics 25:1, pages 1176-1184.
Read now
O. Leeuwenkamp, J. Smith-Palmer, R. Ortiz, A. Werner, W. Valentine, M. Blachier & T. Walter. (2020) Cost-effectiveness of Lutetium [177Lu] oxodotreotide versus best supportive care with octreotide in patients with midgut neuroendocrine tumors in France. Journal of Medical Economics 23:12, pages 1534-1541.
Read now
Elizabeth Mostofsky, Jillian A Dunn, Sonia Hernández-Díaz, Anna C Johansson & Murray A Mittleman. (2019) Eliciting stakeholder preferences for patient-centered research. Patient Preference and Adherence 13, pages 339-349.
Read now
Oriol Solà-Morales, Timm Volmer & Lorenzo Mantovani. (2019) Perspectives to mitigate payer uncertainty in health technology assessment of novel oncology drugs. Journal of Market Access & Health Policy 7:1.
Read now
Pricivel Carrera & Maarten J. IJzerman. (2016) Are current ICER thresholds outdated? Valuing medicines in the era of personalized healthcare. Expert Review of Pharmacoeconomics & Outcomes Research 16:4, pages 435-437.
Read now

Articles from other publishers (3)

Elizabeth Beaulieu, Anne Spanjaart, Ashley Roes, Bernard Rachet, Stéphane Dalle, Marie José Kersten, Delphine Maucort-Boulch & Mohammad S. Jalali. (2022) Health-related quality of life in cancer immunotherapy: a systematic perspective, using causal loop diagrams. Quality of Life Research 31:8, pages 2357-2366.
Crossref
Khalid El Bairi, Ouissam Al Jarroudi, Laura Carpenito, Dario Trapani & Said Afqir. 2021. Ovarian Cancer Biomarkers. Ovarian Cancer Biomarkers 167 185 .
Natalie Ertz-Archambault & Nandita Khera. (2020) Navigating Ethical Practices in the Era of High Cost Hematology. Current Hematologic Malignancy Reports 15:5, pages 401-407.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.